| abstract |
The invention relates to a combination preparation that, as pharmaceutically active constituents, contains at least one active ingredient constituent A and at least one active ingredient constituent B, whereby active ingredient constituent A is a direct stimulator of the soluble guanylate cyclase, and active ingredient constituent B is a lipid reducer. Both active ingredient constituents A and B can be used either simultaneously or in a temporally graduated manner, i.e. exist as a functional unit or separate from one another. |